Breaking News

Verve Therapeutics Inc (VERV)

NASDAQ

Add to/Remove from Watchlist Add to Watchlist

6.01 -0.35 -5.50%

16:00:59 - Closed. Currency in USD ( Disclaimer )

After Hours

6.01

-0.00

-0.00%

16:09:02 - Real-time Data

Type: Equity

Market: United States

Volume: 1,603,987
Bid/Ask: 0.00 / 0.00
Day's Range: 5.88 - 6.43

NASDAQ:VERV Financials

A brief overview of the NASDAQ:VERV financials. This summary provides an overview of the most significant critical numbers from each of its financial reports, including the income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health. Users can select to view data from four periods of either annual or quarterly information, allowing them to track financial performance of Verve Therapeutics Inc over time.

Verve Therapeutics, Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported net loss was USD 45.76 million compared to USD 45.19 million a year ago. Basic loss per share from continuing operations was USD 0.72 compared to USD 0.79 a year ago.For the nine months, net loss was USD 151.72 million compared to USD 116.3 million a year ago. Basic loss per share from continuing operations was USD 2.43 compared to USD 2.26 a year ago.

Annual Quarterly

Advanced Financial Summary

TTM = Trailing Twelve Months

MRQ = Most Recent Quarter

VERV Income Statement

Gross margin TTM -1,060.27%

Operating margin TTM -1,381.45%

Net Profit margin TTM -1,226.43%

Return on Investment TTM -30.17%

Total Revenue Net Income

Period Ending:	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023
Total Revenue	5.7	5.14	3.12	2.09
Gross Profit	-42.68	-41.67	-40.65	-45.17
Operating Income	-56.84	-53.95	-52.33	-58.58
Net Income	-48.74	-48.35	-45.76	-53.98

VERV Balance Sheet

Quick Ratio MRQ 17.02

Current Ratio MRQ -

LT Debt to Equity MRQ -

Total Debt to Equity MRQ 12.49%

Total Assets Total Liabilities

Period Ending:	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023
Total Assets		752.69	612.41	589.13
Total Liabilities		153.19	152.04	123.91
Total Equity	599.5	599.5	460.37	465.22

VERV Cash Flow Statement

Cash Flow/Share TTM -1.79

Revenue/Share TTM 0.19

Operating Cash Flow -

Cash Net Change in Cash

Period Ending:	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023
Period Length:	0 Months	0 Months	0 Months	0 Months
Cash From Operating Activities		-40.68	-11.81	-47.96
Cash From Investing Activities		-8.89	-11.83	33.02
Cash From Financing Activities		177.38	31.92	1.23
Net Change in Cash		127.81	8.28	-13.7

* In Millions of USD (except for per share items)

Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.
Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read Investing.com's comments guidelines and agree to the terms described.

I Agree

VERV Comments

Write your thoughts about Verve Therapeutics Inc

Are you sure you want to delete this chart?

Delete Cancel

Post

Post also to:

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

Kevin J Layes Jun 28, 2023 3:51PM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

Verve is greatly undervalued, with the Lilly Agreement for Manufacturing, Distribtion and marketing in place; expect Verve to soar past $100 by December 2023 and easily approach $250 per share by June 2024 as Eli Lilly are already talking about a full purchase of Verve. The Cholesterol LDL lowering gene drug is testing extremely well and will dominate the industry by replacing the archaic Statin treatment therapies which have been used since the 1980's.... This medicine change in treating cholesterol is grossly overdue and Vereve is at the leading edge of that change!

4 0

Report

MIKHAIL KUZNETSOV Jan 30, 2022 8:31PM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

Added at 28% I wait fly to the moon🚀

0 0

Report

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="234608663">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="234608663" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="234608663" data-reg_ep="block user comments">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="234608663">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d1-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

Are you sure you want to delete this chart?

Delete Cancel

Post

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

US 30	39,487.2	+99.4	+0.25%
US 500	5,218.1	+4.0	+0.08%
Dow Jones	39,512.84	+125.08	+0.32%
S&P 500	5,222.68	+8.60	+0.16%
Nasdaq	16,340.87	-5.40	-0.03%
S&P 500 VIX	12.55	-0.14	-1.10%
Dollar Index	105.175	+0.071	+0.07%

Crude Oil WTI	78.20	-1.06	-1.34%
Brent Oil	82.79	-1.09	-1.30%
Natural Gas	2.252	-0.049	-2.13%
Gold	2,366.80	+26.50	+1.13%
Silver	28.395	+0.030	+0.11%
Copper	4.6523	+0.0673	+1.47%
US Soybeans	1,218.75	+10.75	+0.89%

U.S. 10Y	4.500	+0.051	+1.15%
U.S. 30Y	4.642	+0.042	+0.90%
U.S. 5Y	4.516	+0.056	+1.26%
U.S. 3M	5.406	+0.012	+0.22%
US 10Y T-Note	108.72	-0.38	-0.34%
Euro Bund	130.88	-0.14	-0.11%
10-2 Yield Spread	-34.29	+2.85	+-7.67%

Apple	183.05	-1.27	-0.69%
Alphabet A	168.65	-1.31	-0.77%
Tesla	168.47	-3.50	-2.04%
Amazon.com	187.48	-2.02	-1.07%
Netflix	610.87	-1.22	-0.20%
Meta Platforms	476.20	+0.78	+0.16%
Bank of America	38.45	+0.17	+0.43%

Recent Quotes

	Name	Price	Chg.	Chg. %
	VERV	6.01	-0.35	-5.50%

Market Movers

Name	Last	Chg. %	Vol.
TSLA	168.47	-2.04%	71.53M
AAPL	183.05	-0.69%	40.34M
AMD	151.92	-0.31%	37.43M
AMZN	187.48	-1.07%	34.07M
NVDA	898.78	+1.27%	33.22M
MSFT	414.74	+0.59%	12.66M
BRKa	621,170	+0.87%	14.00K

Name	Last	Chg. %	Vol.
MTD	1,513.03	+17.25%	425.09K
GEN	23.46	+15.34%	13.62M
ANET	314.10	+6.09%	5.16M
CHTR	275.55	+4.40%	1.77M
WAT	350.78	+4.27%	710.53K
FICO	1,330.02	+3.36%	424.53K
CBRE	90.23	+3.19%	1.61M

Name	Last	Chg. %	Vol.
AKAM	91.19	-11.00%	9.72M
PODD	165.90	-6.55%	3.16M
MRNA	117.31	-4.39%	4.23M
IP	38.58	-3.16%	6.28M
ALGN	271.70	-3.10%	729.75K
CZR	36.18	-3.00%	5.22M
ALB	129.60	-2.96%	1.87M